Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

36.4%

4 terminated/withdrawn out of 11 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

27%

3 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 4

2(40.0%)

Phase 3

1(20.0%)

5Total

N/A(2)

Phase 4(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT01795625Completed

OneTouch® Verio™Pro+ Blood Glucose Monitoring System Clinical Accuracy Study in China

Role: lead

NCT03305887Not ApplicableCompleted

Symmetric on Total Knee Arthroplasty (TKA)

Role: lead

NCT02810522Not ApplicableWithdrawn

OneTouch Select® [Brand Name]Plus Blood Glucose Monitoring System(BGMS) Registration Study

Role: lead

NCT01116869Completed

China CellSearch Study

Role: lead

NCT01878981Completed

Health Economics Evaluation of Catheter Ablation Versus Drug Therapy in Atrial Fibrillation (AF) in China

Role: lead

NCT02631499Phase 4Unknown

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

Role: collaborator

NCT01582594Terminated

A Registration Study to Evaluate the Performance of CHIRON® RIBA® HCV 3.0 SIA in HCV Antibody Detection

Role: lead

NCT00938119Terminated

Care China-Diabetes

Role: lead

NCT01589133Completed

Surgiscreen Registration

Role: lead

NCT00869674Phase 3Terminated

GeneSearch™ Breast Lymph Node (BLN) Assay China Registration Study

Role: lead

NCT00768222Phase 4Completed

Coated VICRYL* Plus Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery

Role: collaborator

All 11 trials loaded